2021, Volume 67, Issue 3    
EDITORIAL
177-178 Information of Clarivate    
181-184 EDITORIAL    
185-186 The Institute of Biomedical Chemistry is a member of the world-class Scientific Center for Digital Biodesign and Personalized Health Care    
REVIEWS
187-200 Radchenko E.V., Tarakanova A.S., Karlov D.S., Lavrov M.I., Palyulin V.A.
Ligands of the AMPA-subtype glutamate receptors: mechanisms of action and novel chemotypes
   
EXPERIMENTAL STUDIES
201-212 Kalya M.P., Beisbarth T., Kel A.
Master regulators associated with poor prognosis in glioblastoma multiforme
   
213-221 Tiis R.P., Osipova L.P., Galieva E.R., Lichman D.V., Voronina E.N., Melikhova A.V., Orlov Y.L., Filipenko M.L.
N-aсetyltransferase (NAT2) gene polymorphism and gene network analysis
   
222-230 Orlov Y.L., Galieva A.G., Orlova N.G., Ivanova E.N., Mozyleva Y.A., Anashkina A.A.
Reconstruction of gene network associated with Parkinson disease for gene targets search
   
231-243 Kurpe S.R., Grishin S.Yu., Glyakina A.V., Slizen M.V., Panfilov A.V., Kochetov A.P., Surin A.K., Kobyakova M.I., Fadeev R.S., Galzitskaya O.V.
Antibacterial effects of peptides synthesized based on the sequence of ribosome protein S1
   
244-250 Bibilashvili R.Sh., Sidorova M.V., Dudkina U.S., Palkeeva M.E., Molokoedov A.S., Kozlovskaya L.I., Egorov A.M., Ishmukhametov A.A., Parfyonova Ye.V.
Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor
   
251-258 Kniga A.E., Polyakov I.V., Nemukhin A.V.
In silico specificity determination of neoantigen-reactive T-lymphocytes
   
259-267 Sulimov A.V., Shikhaliev Kh.S., Pyankov O.V., Shcherbakov D.N., Chirkova V.Yu., Ilin I.S., Kutov D.C., Tashchilova A.S., Krysin M.Yu., Krylskiy D.V., Stolpovskaya N.V., Volosnikova E.A., Belenkaya S.V., Sulimov V.B.
Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease
   
268-277 Vassiliev P.M., Spasov A.A., Kochetkov A.N., Perfilev M.A., Koroleva A.R.
Consensus ensemble neural network multitarget model of RAGE inhibitory activity of chemical compounds
   
278-288 Ionov N.S., Baryshnikova M.A., Bocharov E.V., Pogodin P.V., Lagunin A.A., Filimonov D.A., Karpova R.V., Kosorukov V.S., Stilidi I.S., Matveev V.B., Bocharova O.A., Poroikov V.V.
Possibilities of in silico estimations for the development of pharmaceutical composition phytoladaptogene cytotoxic for bladder cancer cells
   
289-294 Zefirov N.A., Mamaeva A.V., Radchenko E.V., Milaeva E.R., Kuznetsov S.A., Zefirova O.N.
Conjugate of podophyllotoxin with chlorambucil: synthesis, biological testing and molecular modeling
   
295-299 Korotkevich E.I., Rudik A.V., Dmitriev A.V., Lagunin A.A., Filimonov D.A.
Predict of metabolic stability of xenobiotics by the PASS and GUSAR programs
   
300-305 Kulakova A.M., Khrenova M.G., Nemukhin A.V.
Molecular mechanism of chromogenic substrate hydrolysis in the active site of human carboxylesterase-1
   
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)